PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-06

Date Title Company
06-Feb-2024 Global Sports Medicine Industry is on a trajectory toward reaching US$ 2,062.7 Million by 2033, Driven Notably by Mental Wellness Initiatives | FMI MARKITWIRED
06-Feb-2024 From Ordinary to Extraordinary: CD Formulation's Remarkable Food Ingredient Launch CD Formulation
06-Feb-2024 Global Downstream Processing Industry is projected to witness an 11.3% CAGR surge by 2032, as per FMI Insight’s analysis MARKITWIRED
06-Feb-2024 Global Pharmaceutical Filtration Industry Projected to Reach US$ 45.08 Billion by 2033 reaching an 8.9% CAGR | FMI MARKITWIRED
06-Feb-2024 Global Molecular Imaging Industry is projected to achieve a value of US$ 15,457.48 Million by the year 2033, with an 11% CAGR | according to FMI MARKITWIRED
06-Feb-2024 Global Multiplex Biomarker Imaging Market Set to Surge at 11.9% CAGR, Driven by Cancer Growth and Personalized Medicine | FMI MARKITWIRED
06-Feb-2024 Global Dermal Fillers and Botulinum Toxin Market Projected to Reach US$ 10.5 Billion by 2032, Reports Industry Analysis MARKITWIRED
06-Feb-2024 Global Diabetic Macular Edema Market Poised for Steady Growth US$ 4.2 Billion by 2032: Despite Challenges, Driven by Rising Diabetes Rates | FMI MARKITWIRED
06-Feb-2024 Global Farm Animal Pharmaceutical Industry Projected to Reach US$ 29.4 Billion by 2032:  FMI MARKITWIRED
06-Feb-2024 Global Oral Controlled Release Drug Delivery Technology Industry to climb to an impressive US$ 68.4 Billion by 2032 | FMI MARKITWIRED
06-Feb-2024 Global MRI-Compatible IV Infusion Pump Systems Market Set to Skyrocket, Reaching US$ 580.3 Million by 2032 | FMI MARKITWIRED
06-Feb-2024 Global Oral Solid Dosage Pharmaceutical Formulation Industry Set to Surge with a Robust 6.4% CAGR by 2032, according to FMI MARKITWIRED
06-Feb-2024 APONTIS PHARMA successfully completes performance and efficiency improvement program APONTIS PHARMA AG
06-Feb-2024 Global Medical Bionic Implant and Exoskeleton Market Projected to Reach US$ 1,361.90 Million by 2033 | FMI MARKITWIRED
06-Feb-2024 IRLAB’s Pioneering Phase IIb Study with Pirepemat - React-PD - Provides New Insights in Specific Parkinson's Patient Population and Enables a Data Driven Prediction of Study Timelines AccessWire
06-Feb-2024 Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG Kinarus Therapeutics Holding AG